Local Delivery of Chlorotoxin-Embedded Chimeric Antigen Receptor Cells for the Treatment of Recurrent Glioblastoma: Early Safety and Disease Control
Abstract：Glioblastoma (GBM) is a common and highly invasive central nervous system malignant tumor, characterized by a unique immunosuppressive tumor microenvironment [1]. Although chimeric antigen receptor (CAR-T) cell therapy has achieved breakthrough progress in the treatment of hematological malignancies, its efficacy in GBM remains limited.
Machine-generated Keywords：
Publication Date：2025-10-20
Online Publishing Date：2025-12-01(First online date of this platform, not the publication date of the document)
Pages：1( 629 )